Connect with us

Health

Please Take 30 Seconds to Support Access to TB Diagnostics

SHARE:

Published

2 years ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

Treatment Action Group has once again called upon the diagnostics company Danaher to lower the price of its GeneXpert tests for tuberculosis (TB) and other diseases to $5 each, in accordance with publicly available information on the costs of manufacturing. Now, we’re asking our supporters and allies to sign this petition demanding Danaher take this simple, lifesaving action to get more people diagnosed with TB and connected to care. Sign on now!TB kills over 1.5 million people each year, but TB services around the world remain perilously underfunded. The high cost of diagnostics gobbles up limited resources that could otherwise be used for treatment and support, making it harder to get as many people as possible tested and cured. For years, TAG has teamed up with the MSF Access Campaign, Partners in Health (PIH) and other allies on the Time for 5 Campaign to advocate for $5 tests across diseases, which would still cover production costs as well as a modest profit. Last year, Danaher announced that its subsidiary Cepheid would lower the price of its MTB/RIF Ultra TB test to $7.97, but it continues to charge $15 per cartridge for extensively drug-resistant (XDR) TB tests, as well as other test assays for HIV, HCV, and more. The company has also failed to fulfill its commitment to transparency regarding manufacturing costs and revenue, without which its claims are not credible.
To get people the treatment and care that they need, we need rapid and accurate diagnostics to reach everyone, everywhere. We won’t stop holding Danaher and Cepheid accountable until all TB-affected communities have access to GeneXpert diagnostic tests. We hope you’ll join us in sending a message, loud and clear: DANAHER, IT’S TIME FOR 5! 
 
Contact Us: Treatment Action Group, 90 Broad Street, Suite 2503, New York, New York 10004, 212-253-7922. [email protected]. Treatment Action Group (TAG) is an independent, activist, and community-based research and policy think tank committed to racial, gender, and LGBTQ+ equity; social justice; and liberation, fighting to end HIV, tuberculosis (TB), and hepatitis C virus (HCV). Please consider supporting this work by making a donation today.

Share this article:

Share this:
Related Topics:
Press release

This article repeats in part or in full the contents of a press release issued by the author, who guarantees its legality and truthfulness. No payment or inducement was received by EU Reporter for its publication.

EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending